Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,353 | 0 | 0 | N/A | 0 |
| Marketable Securities | 81,597 | 0 | 0 | N/A | 0 |
| Receivables | 2,443 | 0 | 0 | N/A | 0 |
| TOTAL | $127,372 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 11,673 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 5,981 | 0 | 0 | 0 | 0 |
| TOTAL | $17,654 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $145,026 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,182 | 0 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 4,594 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 4,085 | 0 | 0 | N/A | 0 |
| Other current liabilities | 815 | 0 | 0 | N/A | 0 |
| TOTAL | $36,905 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,500 | 0 | 0 | N/A | 0 |
| Deferred Revenues | 24,229 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,531 | 0 | 0 | 0 | 0 |
| TOTAL | $62,309 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $99,214 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,285 | N/A | N/A | N/A | N/A |
| Retained earnings | -148,835 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 187,219 | 0 | 0 | 0 | 0 |
| TOTAL | $45,812 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $145,026 | $0 | $0 | $0 | $0 |